July 10, 2024

Topical Discussion

Video

Quick Takes: Amole Ojo on Risks of Digoxin Use in HFrEF Patients

05:20

Digoxin’s risks in HFrEF patients with ICDs are well-known, but the magnitude may surprise, Amole Ojo, MD, explains.

Heart Failure

Amole Ojo

quick takes

Topical Discussion

Advertisement

Latest Videos

28:13

Beyond the Data: Top Cardiology Trials of 2024

15:29

Beyond the Data: Digesting the 2024 ESC CCS Guidelines

17:12

Ultralow-Contrast PCI: Why, What, and How?

23:49

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

55:41

CathWorks FFRangio: Coronary Physiology Redefined

21:08

Hearing and Learning From Patients Undergoing AVR

08:59

Fellows Forum: Should CV Surgeons Train in Interventional?

11:34

Fellows Forum: Is It Safe to Allow Fellows Perform Complex PCI?

09:44

TCT 2024: Shark Tank Award

02:37

Next Generation TAVR Planning with DASI Simulations: Artificial Intelligence and Prediction-Based Algorithms

11:05

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

00:20

Cerebral Embolic Protection – A Next Generation Approach for Contemporary TAVR Practice

Partner Content

Explore All

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.